Cord blood disorders is speculative, some research has been done in other areas. Any such potential beyond blood and immunological uses is limited by the fact that cord cells are hematopoietic stem cells (which can differentiate only into blood cells), and not pluripotent stem cells (such as embryonic stem cells, which can differentiate into any type of tissue). Cord blood has been studied as a treatment for diabetes. However, apart from blood disorders, the use of cord blood for other diseases is not in routine clinical use and remains a major challenge for the stem cell community. Along with cord blood, Wharton's
American Academy of Sleep Medicine better sleep. Its stated mission is to improve sleep health and promote high quality, patient-centered care through advocacy, education, strategic research, and practice standards. Membership is open to physicians, researchers and other health care professionals who specialize in the study, diagnosis and treatment of disorders of sleep and daytime alertness, including some who are not Americans. The latest findings in sleep medicine are published in the official peer-reviewed journal of the AASM: The AASM also publishes Clinical Practice Guidelines, Position Papers and Consensus Documents for sleep medicine physicians with recommendations for the diagnosis and treatment of sleep and circadian rhythm